Richard P Meijer

11PUBLICATIONS
52CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)SexualitiesLiquid biopsiesCondensed matter characterisation technique development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 31, 2026
ATR inhibitors synergise with mitomycin C to enhance cytotoxicity in patient-derived non-muscle invasive bladder cancer organoids.

|Jun 09, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.

Chantal F Stockem, Alberto Gil-Jimenez, Hamza Ali

|Feb 24, 2024
Perspectives and Concerns on Late Effects Regarding Sexuality among Adolescents and Young Adults Treated for Testicular Germ Cell Tumor: The PRICELESS-Study-A Qualitative Study.

Stefan T Kuiper, Daniëlle Zweers, Britt B M Suelmann

|Dec 15, 2023
Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation.

Bastiaan J Viergever, Daniëlle A E Raats, Veerle Geurts

|Apr 24, 2023
Feasibility of clinical studies of chemical exchange saturation transfer magnetic resonance imaging of prostate cancer at 7 T.

Daan J Reesink, Catalina S Arteaga de Castro, Tijl Van der Velden

|Nov 13, 2021
Significant Inter- and Intralaboratory Variation in Gleason Grading of Prostate Cancer: A Nationwide Study of 35,258 Patients in The Netherlands.

Rachel N Flach, Peter-Paul M Willemse, Britt B M Suelmann

Pageof 2

Frequent Collaborators

4 joint publications

Joost M Blok

3 joint publications

Onno Kranenburg

2 joint publications

Oscar R Brouwer

2 joint publications

Michiel S van der Heijden